This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Finance & Accounting for Bioscience
September 16-17, 2025
Sheraton BostonBoston, MA

Finance & Accounting Attendees

CFOs, Chief Accountants, and VPs of Finance & Accounting

Vice President, Finance — Corbus Pharmaceuticals

Chief Financial Officer — Eisai

Vice President & Chief Accounting Officer — Intellia Therapeutics

Chief Financial Officer — Collegium Pharmaceuticals

Chief Financial Officer — InVivo Biosystems

Vice President & Corporate Controller — Longeveron

Chief Financial Officer & Head of Operations — Radius Health

Vice President of Finance & Treasurer — Sail Biomedicines

Vice President of Finance — Structure Therapeutics

Senior Vice President & Chief Financial Officer — Thea Pharma

Vice President, Financial Planning & Analysis — Intellia Therapeutics

Vice President, Controller — Agios Pharmaceuticals

Chief Financial Officer — Alentis Therapeutics

Vice President of Finance — Alkeus Pharmaceuticals

Chief Financial Officer — Ascidian Therapeutics

Vice President, Finance — Biotheryx

Vice President, Financial Planning & Analysis — Collegium Pharmaceuticals

Vice President, Strategic Finance — EyePoint Pharmaceuticals

Chief Accounting Officer — Immuneering

Vice President, Chief Accounting Officer — Mersana Therapeutics

Board Member — Neuropace

Vice President, Finance & Controller — PepGen

Chief Financial Officer — X4 Pharmaceuticals

Chief Accounting Officer — Centessa Pharmaceuticals